Tallenna
Acute Myelogenous Leukemia in Childhood
nidottu, 1990
englanti
Another result of the BFM-83 study was the definition of two risk groups on the basis of standardized treatment, which has lead to a risk-adapted treatment strategy in the third ongoing trial, AML-BFM- 87. Munster, April 1990 Ursula Creutzig Jorg Ritter Gunther Schellong Contents 1 Introduction . . . . . . . . . . . . . . . . . . . . . 1 .
- Alaotsikko
- Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies
- Toimittaja
- Ursula Creutzig, Jörg Ritter, Günther Schellong
- Painos
- Softcover reprint of the original 1st ed. 1990
- ISBN
- 9783540520702
- Kieli
- englanti
- Paino
- 310 grammaa
- Julkaisupäivä
- 5.10.1990
- Sivumäärä
- 163
